Impairment of the endothelial glycocalyx in cardiogenic shock and its prognostic relevance

Shock

Volumn 43, Issue 5, 2015, Pages 450-455

  Jung, Christian ^a   Fuernau, Georg ^b   Muench, Phillip ^b   Desch, Steffen ^c   Eitel, Ingo ^c   Schuler, Gerhard ^b   Adams, Volker ^b   Figulla, Hans R ^a   Thiele, Holger ^c  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^b UNIVERSITY OF LEIPZIG   (Germany)

^c UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

Cardiogenic shock; endothelium; glycocalyx

Indexed keywords

CREATINE KINASE; CREATININE; HEPARAN SULFATE; SYNDECAN 1; TROPONIN T; GLYCOSAMINOGLYCAN; PROTEOGLYCAN;

ACUTE HEART INFARCTION; ADULT; AGE; AGED; ARTICLE; BLOOD CLOT LYSIS; CARDIOGENIC SHOCK; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; CREATININE BLOOD LEVEL; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLYCOCALYX; HEART EJECTION FRACTION; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; INTRAAORTIC BALLOON PUMP; LACTATE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PREDICTIVE VALUE; PROGNOSIS; ADVERSE EFFECTS; AORTA; BLOOD; CHEMISTRY; HEART CATHETERIZATION; HEART INFARCTION; METABOLISM; MICROCIRCULATION; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PATHOLOGY; PROCEDURES; RANDOMIZED CONTROLLED TRIAL; SHOCK, CARDIOGENIC; TIME; TREATMENT OUTCOME; VERY ELDERLY;

AGED; AGED, 80 AND OVER; AORTA; CARDIAC CATHETERIZATION; FEMALE; GLYCOCALYX; GLYCOSAMINOGLYCANS; HEPARITIN SULFATE; HUMANS; INTRA-AORTIC BALLOON PUMPING; MALE; MICROCIRCULATION; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; ODDS RATIO; PROGNOSIS; PROTEOGLYCANS; SHOCK, CARDIOGENIC; SYNDECAN-1; TIME FACTORS; TREATMENT OUTCOME;

EID: 84928468770     PISSN: 10732322     EISSN: 15400514     Source Type: Journal    
DOI: 10.1097/SHK.0000000000000329     Document Type: Article

References (27)

1. Goldberg RJ, Spencer FA, Gore JM, Lessard D, Yarzebski J: Thirty-year trends (1975 to 2005) in the magnitude of, management of, and hospital death rates associated with cardiogenic shock in patients with acute myocardial infarction: a population-based perspective. Circulation 119(9):1211-1219, 2009.
2. Jung C, Ferrari M, Roediger C, Fritzenwanger M, Goebel B, Lauten A, Pfeifer R, Figulla HR: Evaluation of the sublingual microcirculation in cardiogenic shock. Clin Hemorheol Microcirc 42(2):141-148, 2009.
3. Adrie C, Adib-Conquy M, Laurent I, Monchi M, Vinsonneau C, Fitting C, Fraisse F, Dinh-Xuan AT, Carli P, Spaulding C, et al.: Successful cardiopulmonary resuscitation after cardiac arrest as a "sepsis-like" syndrome. Circulation 106(5):562-568, 2002.
4. Richardt G, Munch G, Neumann FJ, Rauch B, Kurz T: Systemic and cardiac catecholamines during elective PTCA and during immediate PTCA for acute myocardial infarction. Basic Res Cardiol 92(1):52-60, 1997.
5. Visser M, Vermeulen MA, Richir MC, Teerlink T, Houdijk AP, Kostense PJ, Wisselink W, de Mol BA, van Leeuwen PA, Oudemans-van Straaten HM: Imbalance of arginine and asymmetric dimethylarginine is associated with markers of circulatory failure, organ failure and mortality in shock patients. Br J Nutr 107(10):1458-1465, 2012.
6. Hermansen SE, Kalstad T, How OJ, Myrmel T: Inflammation and reduced endothelial function in the course of severe acute heart failure. Transl Res 157(3):117-127, 2011.
7. Van Teeffelen JW, Brands J, Stroes ES, Vink H: Endothelial glycocalyx: sweet shield of blood vessels. Trends Cardiovasc Med 17(3):101-105, 2007.
8. Reitsma S, Slaaf DW, Vink H, van Zandvoort MA, Oude Egbrink MG: The endothelial glycocalyx: composition, functions, and visualization. Pflugers Arch 454(3):345-359, 2007.
9. Mulivor AW, Lipowsky HH: Inflammation-and ischemia-induced shedding of venular glycocalyx. Am J Physiol Heart Circ Physiol 286(5):H1672-H1680, 2004.
10. Grundmann S, Fink K, Rabadzhieva L, Bourgeois N, Schwab T, Moser M, Bode C, Busch HJ: Perturbation of the endothelial glycocalyx in post cardiac arrest syndrome. Resuscitation 83(6):715-720, 2012.
11. Ostrowski SR, Pedersen SH, Jensen JS, Mogelvang R, Johansson PI: Acute myocardial infarction is associated with endothelial glycocalyx and cell damage and a parallel increase in circulating catecholamines. Crit Care 17(1):R32, 2013.
12. Thiele H, Schuler G, Neumann FJ, Hausleiter J, Olbrich HG, Schwarz B, Hennersdorf M, Empen K, Fuernau G, Desch S, et al.: Intraaortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock: design and rationale of the Intraaortic Balloon Pump in Cardiogenic Shock II (IABP-SHOCK II) trial. Am Heart J 163(6):938-945, 2012.
13. Thiele H, Zeymer U, Neumann FJ, Ferenc M, Olbrich HG, Hausleiter J, de Waha A, Richardt G, Hennersdorf M, Empen K, et al.: Intraaortic balloon pump in cardiogenic shock: intra-aortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock (IABP-SHOCK II): final 12 month results of a randomised, open-label trial. Lancet 382(9905):1638-1645, 2013.
14. Thiele H, Zeymer U, Neumann FJ, Ferenc M, Olbrich HG, Hausleiter J, Richardt G, Hennersdorf M, Empen K, Fuernau G, et al., I.-S. I. T. Investigators: Intraaortic balloon support for myocardial infarction with cardiogenic shock. N Engl J Med 367(14):1287-1296, 2012.
15. Danielli JF: Capillary permeability and oedema in the perfused frog. J Physiol 98(1):109-129, 1940.
16. Becker BF, Chappell D, Bruegger D, Annecke T, Jacob M: Therapeutic strategies targeting the endothelial glycocalyx: acute deficits, but great potential. Cardiovasc Res 87(2):300-310, 2010.
17. Rehm M, Bruegger D, Christ F, Conzen P, Thiel M, Jacob M, Chappell D, Stoeckelhuber M, Welsch U, Reichart B, et al.: Shedding of the endothelial glycocalyx in patients undergoing major vascular surgery with global and regional ischemia. Circulation 116(17):1896-1906, 2007.
18. Nelson A, Berkestedt I, Schmidtchen A, Ljunggren L, Bodelsson M: Increased levels of glycosaminoglycans during septic shock: relation to mortality and the antibacterial actions of plasma. Shock 30(6):623-627, 2008.
19. Bruegger D, Schwartz L, Chappell D, Jacob M, Rehm M, Vogeser M, Christ F, Reichart B, Becker BF: Release of atrial natriuretic peptide precedes shedding of the endothelial glycocalyx equally in patients undergoing on-and off-pump coronary artery bypass surgery. Basic Res Cardiol 106(6):1111-1121, 2011.
20. Jung C, Lauten A, Ferrari M: Microcirculation in cardiogenic shock: from scientific bystander to therapy target. Crit Care 14(5):193, 2010.
21. Chappell D, Jacob M, Hofmann-Kiefer K, Rehm M, Welsch U, Conzen P, Becker BF: Antithrombin reduces shedding of the endothelial glycocalyx following ischaemia/reperfusion. Cardiovasc Res 83(2):388-396, 2009.
22. Zeng Y, Adamson RH, Curry FR, Tarbell JM: Sphingosine-1-phosphate protects endothelial glycocalyx by inhibiting syndecan-1 shedding. Am J Physiol Heart Circ Physiol 306(3):H363-H372, 2014.
23. Kozar RA, Peng Z, Zhang R, Holcomb JB, Pati S, Park P, Ko TC, Paredes A: Plasma restoration of endothelial glycocalyx in a rodent model of hemorrhagic shock. Anesth Analg 112(6):1289-1295, 2011.
24. Annecke T, Rehm M, Bruegger D, Kubitz JC, Kemming GI, Stoekelhuber M, Becker BF, Conzen PF: Ischemia-reperfusion-induced unmeasured anion generation and glycocalyx shedding: sevoflurane versus propofol anesthesia. J Invest Surg 25(3):162-168, 2012.
25. Kolarova H, Ambruzova B, Svihalkova Sindlerova L, Klinke A, Kubala L: Modulation of endothelial glycocalyx structure under inflammatory conditions. Mediators Inflamm 2014:694312, 2014.
26. Ebong EE, Lopez-Quintero SV, Rizzo V, Spray DC, Tarbell JM: Shear-induced endothelial NOS activation and remodeling via heparan sulfate, glypican-1, and syndecan-1. Integr Biol (Camb) 6(3):338-347, 2014.
27. Tromp J, van der Pol A, Klip IJT, de Boer RA, Jaarsma T, van GilstWH, Voors AA, van Veldhuisen DJ, van der Meer P: Fibrosis marker syndecan-1 and outcome in patients with heart failure with reduced and preserved ejection fraction. Circ Heart Fail 7(3):457-462, 2014.